In this study, PSMA-PET/MRI correctly diagnosed prostate cancer in 119 of 122 patients (97.5%).The diagnostic accuracy for T staging was 82.5%, for T2 stage was 85%, for T3a stage was 79%, for T3b stage was 94%, and for N1 stage was 93% [81]. The gene discussed is FOLH1; the disease is prostate carcinoma.